One Patient's Positive Perspectives

Archive for the ‘Research’ Category

Lupus Fact & Blog of the Day No. 2 – Lupus Unfairly Discriminates!


Today’s Lupus Blogger

Lupus Awareness Blogger No. 2

Diva is a Latina Jew born in Venezuela, raised in Argentina and now lives in Texas.  She has well over two hundred blog followers, and sub-titles her blog, “Living with Lupus and Still Fabulous.”  Diva started blogging soon after she was diagnosed with lupus three years ago, and describes hers as “one of those many cases that should have been diagnosed years before.” Her final clues to a lupus diagnosis were constant flu-like body aches, joint pains, headaches, limb numbness/weakness, skin rashes and rapid hair loss. A positive scalp biopsy for lupus helped complete a conclusive diagnosis, along with meeting many of the 11 diagnostic criteria for lupus.

 Diva...

Wake-up Call to Enjoy Life

Diva has a psychology degree, is trying to finish her graduate degree, and worked as a project coordinator/research manager in health-services research. Her team’s research in medical decision-making and proactive collaborative communication between the patient and the doctor surely prepared her for a productive relationship with her doctors now.

Diva is an active member of the Lupus Foundation of America – Texas Gulf Chapter. She describes how “Lupus has not only put everything into perspective, but it has become her wake-up call to enjoy life, my family and friends.” She blogs about her love of music, art, and self-expression.

image

Diva’s Pill Bottle Pop Art

Diva covers a variety of topics in her blog. A favorite recent post has some impressionist pictures of her night stand pill bottle collection “still life” all taken and morphed with the camera tools on her cell phone.

Lupus Truth No. 2 – Lupus unfairly discriminates!

Understanding Lupus: It doesn’t seem fair, but lupus definitely discriminates.  Although our federal laws forbid discrimination based on gender, there are no laws of auto-immunity that follow those edicts.

Unfortunately, 90 percent of the people who develop lupus are women.

Lupus further discriminates because it is two to three times more prevalent among women of color — African-Americans, Hispanics/Latinos, Asians, Native Americans, Alaska Natives, Native Hawaiians and other Pacific Islanders — than among Caucasian women.

To learn more about this lupus fact, please read my post from  May 2, 2012.

Plan to POP — Put on Purple — for Lupus May 17th

Remember to hunt down your violet duds to get ready to “POP” — Put on Purple — for Lupus on Friday, May 17th!

Lupus Adventurer in Conference and Classroom

bf deep purple

A month of education!

It is hard to believe that it has been a few weeks since I have had a minute to sit down to write!  It seems that April was filled with nothing but classrooms, conferences and training sessions.  I have been an attendee, performer, and instructor all in a short one-month time keeping very, very busy.  My educational adventures are not quite complete, but this has truly been a month full of learning.

Duet

LA (left) sings duet with friend

Early in April I had the pleasure of attending a statewide women’s Bible conference hosted annually by my church.  I shared the privilege of singing a duet at one of the sessions with one of my best friends.  The music went well, and the weekend was one of spiritual recharge, excellent bible teaching, good music and warm fellowship.  I saw many old friends, and made a few new ones before getting ready to leave Arizona for the east coast.

Hair curls, manicures, pedicures but no lupus cures...

Flying out to Maryland

Next, I flew out to Maryland for a week-long professional legal management conference, and during off hours enjoyed some fresh salmon dinners and sailboat watching on the shores of the Potomac.  In my hotel room I worked on a PowerPoint presentation I would be using the following week back in Arizona.

Returning to work the following Monday, I jumped right into my role as teacher.  Enlisted by the Human Resources and Safety Offices to teach a two-week series of classes, as part of my government employer’s Safety Training Week, my education-filled month continues!

Ergonomics Wordle

Teaching Ergonomics Class

Every morning this past week (and all of next) is taken up teaching classes to my fellow employees about Ergonomics and Back/Lifting Safety.  I have enjoyed getting to know co-workers better, and found interaction with the class members very enjoyable.  With the help of my assistant, it has proven to be a bit more fun than work, and I am grateful to share some information that can help prevent co-workers’ injury!  I am looking forward to the remaining classes next week.

As part of our safety training week, I also attended a class on CPR, and learned the new “no breathing” method of cardiac chest compression.  I was pleasantly surprised to learn that, even with my joint and lupus arthritis challenges, I was able to do this type of CPR.  I had always been afraid I would not hold up long enough to do anyone any good in an emergency.  I learned that using my body weight to make the compressions, and not my not-so-strong muscles, I could potentially save someone’s life without wearing myself out before paramedics could arrive.  Click here, to read more about this easy to learn CPR method.

Dr. Amy H. Kao, Director of Biomedical Informatics at Lupus Center of Excellence at  WPAHS

Dr. Amy H. Kao, Director of Biomedical Informatics at Lupus Center of Excellence at WPAHS

This simple live-saving CPR would be a good thing for lupus patients, their friends and family (perhaps anyone) to learn.  To find out more about lupus and the heart, check out this 2009 Lupus Foundation of America educational web chat with one of the nation’s leading lupus and cardiology researchers, Dr. Amy H. Kao, M.D., Cardiovascular Health and Lupus.

Dr. Kao explains that, “young women with lupus have as high as 50-fold increased risk of having a heart attack compared to healthy women of similar age.”

Perhaps, after considering all my educational activities, the new CPR method was the most important.

Let’s hope I never have to find out!

iGive.com Lupus donations with each online purchase

A new way to give to lupus!

This is an awesome way to give to support for local Lupus research, lupus awareness and patient services without spending an extra penny from your own wallet!  The online stores make donations to a non-profit cause while you shop.

You and your friends can make a real difference for Lupus Foundation of America, AZ Chapter or another worthy non-profit organization through your everyday online shopping.

Here’s how you can sign up to start making free donations to the Lupus Foundation of America, Arizona Chapter:

All you have to do is join iGive.com, install the iGive Button, and keep it installed for 90 days.

Follow the link here to iGive.com.

Sign up for iGive.com and follow the simple on-screen instructions to install the button to your browser menu.

  • Always Free – the stores pay
  • The average iGive.com shopper raises over $50 a year with the iGive Button
  • Easy to install and uninstall browser add-on / extension for PCs and Macs
  • No pop ups, ads, toolbars, special search engine, or unwanted emails
  • No sharing your email or other information
  • At least $5 is received by the Lupus Foundation of America, AZ Chapter, even if you don’t shop. All you need to do is keep the Button installed for 90 days.

A donation for each purchase

Then, each time you make an online purchase, online vendors make donations to the Lupus Foundation of America, Arizona Chapter, or another non-profit organization of your choice, at no cost to you.

If you sign up through the link in this post, it will also increase the donation amounts for my purchases.  If you also refer others to iGive.com from your own blog or Facebook page, each time you make purchases online, an extra donation will also be made on your behalf for their purchases.

Donate to lupus while shopping!

To see the Lupus Foundation of America, Arizona Chapter (LFA, AZ) link to information about this FREE donation option, go to their official website.  You can also sign up directly from the LFA, AZ link, rather than going through the link here on my blog.

Just by signing up, even without making a purchase, my first iGive.com $5.00 donation was made today.  My next online purchase will donate another $5.00, and more will be donated with each future purchase.

Please consider joining me in using this creative method of raising support for Lupus in Arizona!

[Please Note:  Lupus Adventurer receives no profit or personal gain of any type through her own or a reader's use of the iGive.com donation services.  The only beneficiary of this service is the Lupus Foundation of America, Arizona Chapter or another designated non-profit organization selected by the participant.]

Lupus and Benlysta – after 10 months & infusion #12

12th Benlysta Infusion

This week I received my 12th Benlysta infusion, and am glad to report moderate success with it as a contributor to controlling my lupus.   While I had keenly anticipated it might be as miraculous as the Rituxan (Rituximab) infusions I received several years ago, it has fallen far short of that hope.  However, the drug I received during the phase three clinical trials of Rituximab proved to have remarkable effectiveness for some lupus patients, but treatment with it presented grave danger for others.

While I entered a five-year dramatic near remission of my lupus after receiving just two infusions of Rituximab, a few unfortunate patients in the clinical trials lost their lives to a fatal brain infections.  A normally harmless common childhood virus was re-awakened in some of the clinical trial patients, causing their untimely deaths.  The number of these deaths was compared to the total number of patients in the trial, and it was clear the fatalities were too many to be a coincidence.

Benefits v. Risks

Benefits of effective drugs may not outweigh the risks

The Rituximab deaths demonstrated that lupus patients seemed to have too much risk to take the drug, and the excitement about Rituximab as a treatment for lupus cooled off quickly.  The FDA did not approve it and many insurance companies will not pay for Rituximab to treat Lupus.  Although Rituximab is FDA approved and widely used with outstanding results for rheumatoid arthritis, certain cancers and many other auto-immune diseases, Rituximab proved much too risky for lupus patients.  The potential benefits of Rituximab for Lupus clearly did not outweigh the great risks.

I also thank God for many answered prayers and His gracious protection through the clinical trial, and that I was spared from developing a horrible infection.  I am thankful for the many people who prayed for me during the time I was receiving Rituximab* infusions, knowing there were possible great risks, and even a remote possibility of death.  Although I was more concerned about a possible allergic reaction, there was an even greater risk from infection revealed during the trial.

So, I now continue to take Belimumab infusions, and do enjoy its moderate help with controlling my lupus. Still,  I cannot help but wonder how I might feel right now if Rituximab had been safer, and if it were still available to me.  One of the important issues patients must realize when they take part in clinical trials, is that, although they may feel great in response to new drugs being investigated, the medication being studied may not continue to be available.  If access to drugs taken in a clinical trial stops and they are not approved by the FDA, then participants must be ready to accept a return to using less effective drugs and a possible return to more active lupus.

safe “okay” is better that dangerous miracles

“Okay” with safe drugs is better than dangerous miracles

For me there is some clear amount of disappointment to cope with after having received both Rituximab and Belimumab infusions.  But, still I am very thankful for the five years of dramatically improved health that I enjoyed after Rituximab.  I am also very thankful to for the slower, but clearly modest improvement of my lupus after ten months of Belimumab infusions.

Although after almost one year of Belimumab I hoped to feel absolutely wonderful, instead have to describe how I feel today as just “okay.”  Okay is better than where I was  a year ago, and that is still very important progress in treating my lupus.  It is not miraculous, like Rituximab seemed to me, but it gives acceptable improvement.  I’ll take it and thank God daily for the ability to receive this helpful and safer FDA-approved treatment.

opportunity to make a difference

Participation in clinical trials makes a difference

It is also very important to me to know that my participation in a clinical trial contributed to the greater process of helping find new drugs that are safe and effective for treating lupus.  Even though the drug I took did not ultimately become a help to future lupus patients, the clinical trial helped in other ways.  If not for patients like me, being willing to put their hopes and health at some level of risk, new drugs would never be found for lupus.

The safest trials to take part in are phase three clinical trials, when medicines are tested that have already proven effective in phase one and phase two trials.  The phase three trials help verify appropriate doses, and measure how effective the drugs are in treating a specific disease.  Phase 3 trials help doctors know 1) how much medicine to give, 2) how often to give it, and 3) how well the medicine works. Progress in finding these new drugs would never be reached without patients and their doctors being willing to participate in the lupus adventure and risks of joining a clinical trial.  I am still grateful for that opportunity to make a difference.

*[Errata:  The incorrect word "Benlysta" was deleted and correct word "Rituximab" was inserted after publishing.]

Other posts about Rituxan and Benlysta:

Lupus Rituxan treatment denied by insurance company
Pending FDA approval of new lupus drug Benlysta

Lupus, and Benlysta in my future…

Benlysta Infusions for Lupus – Day One

Benlysta infusions for lupus – Day 15

Benlysta Infusions for Lupus – Day 30

Benlysta Infusions for Lupus – Day 60

Benlysta Infusions for Lupus – Day 90 – Thanksgiving

Lupus and Benlysta after 21 weeks

Lupus post-infusion infection, steroids and the E.B. effect

Benlysta & Rituxan infusions for Lupus: the tortoise and the hare

Lupus and Benlysta – 25 Weeks and Infusion #8

Lupus, Benlysta infusions and almost glorious mornings

Lupus and postponing a Benlysta infusion

Lupus, singing and a visiting hummingbird

Lupus and Benlysta after 7 months – Infusion #9

Benlysta infusion #10 while pondering the good, the bad and the ugly of lupus
Diagnosis and Treatment of Lupus: Fact #12 – Lupus requires multiple medicines!

Prognosis and Hope: Lupus Fact #28 – Normal life span expected with current treatment standards

Prognosis and Hope: Lupus Fact #31 – Lupus research lengthens lives!

Prognosis and Hope: Lupus Fact #31 – Lupus research lengthens lives!

Prognosis and Hope: Today, people with lupus are leading healthier lives and living longer than at any time in history, thanks to researchers who continue to discover more about the underlying science of the immune system. When I was first diagnosed with lupus almost twenty years ago, this was not the case, and prognosis that people heard was not encouraging.  Today life expectancy for lupus patient is much longer, and the information available about lupus life expectancy is more accurate and much more encouraging!

Other people’s negative lupus outlook

Lupus diagnosis, and other people’s’ negative idea of the prognosis

The first thing I heard from people after my lupus diagnosis was that my life expectancy might only be about ten years.  Some people acted as if I had received a death sentence, and it sure sounded like the statistics were pretty grim. I was a young wife and mother, my doctor was more encouraging than everyone else, and I was concerned, confused, and frankly a little afraid.  Why did everyone else think I was going to die prematurely, but my doctor said lupus was the good news in the diagnosis he had considered.  I was diagnosed twenty years ago.

Lupus information in “dark ages” before the Internet

Lupus information in the “dark ages” before the Internet

My lupus diagnosis came during the early days of the Internet, when finding out information required physically going to a library and spending time in study. Although this sounds very cliché, “back then” we didn’t have the world’s information at our fingertips, not at work, at home, and certainly not in mobile devices! We didn’t even handheld electronic devices then, and there were only a few of the earliest mobile phones out there, in the hands of the wealthy few.  It was definitely a totally different age and time, very unlike today’s information highway and instantaneous access to knowledge.  What a vast difference a mere two decades have made!

Most of the medical and patient information books about lupus in the libraries were ten to fifteen years old.  The bookstores were a little better, but not much.  They all said much the same thing about lupus life expectancy as the widely held “live ten years” fable.  There was little up-to-date information available to support a different outlook. Unfortunately, the false negative impression about life expectancy prevailed in what people thought then about lupus. Even though researchers had better information, the word was getting out very slowly, the old-fashioned way.  Access to accurate information was slim and hard to find.  Everyone pretty much still believed the ill-conceived fable.  I asked myself and my doctor, “do I only have about ten years to live?”  Fortunately, he knew better and encouraged me to be positive, but convincing other people was another matter!

Positive research results misconceived as negative news

How the grim 10-year lupus life expectancy myth started

I recently learned where the original wrong concept about lupus life expectancy started.  Years ago, a major lupus research study was conducted over a ten-year period,  and the patients’ lupus status was  carefully followed for 10 years, and then the study ended.  The widely publicized results of this ten-year research project were shared with the medical community and the public.  The outcome was very good news for lupus patients.  At the end of the 10 year study, more than 80 percent of the lupus patients who started out taking part in the study were still alive. But that is not what people “heard” when they learned about study.

Somehow, the news reports and information that was repeated from report to report about the study became slightly turned-around and turned upside-down to communicate a vastly different, almost opposite message! Instead, a false conclusion was propagated, misinterpreting the ten-year study results to say that “life expectancy for lupus patients is ten years.” Maybe it would have been less confusing if the researchers had explained it this way, “most lupus patients survive at least ten years after their diagnosis, or longer.”  But the idea went out that way, and that is what seemed to stick in everyone’s minds.  So, when I received my prognosis, the first thing people thought was that I would probably die in ten years.  I am so glad that was wrong!!

New lupus outlooks!

Myth-blasting information, new lupus drugs and better prognosis

Now, there are some wonderful brand new medicines, such as the new biologic drugs like Rituximab (Rituxan) and Belimumab (Benlysta,) the latter of which was approved over a year ago by the FDA just for lupus, in March of 2010.  Belimumab is the first new drug approved by the FDA for systemic lupus in over fifty years.  Before that, the FDA had only approved three drugs for lupus: 1) aspirin, 2) prednisone, and 3) hydroxycholoroquine (Plaquenil.)

Our doctors and rheumatologists now know so much more about lupus than when the old “10-years” study was done.  And even though that study really gave good news, the news is even better now.  Doctors have learned more about lupus in the last ten to twenty years than in the 100 years before that.  There are more new biologic drugs in research and development, and many are successfully progressing through clinical trials. Some of these new drugs will stand next to belimumab to help treat lupus in more effective ways.

This is the best time in history to have Lupus… although Lupus is still incurable, it is very, very treatable!

Yes, lupus can be fatal.  In its most severe, organ-threatening flares, it can attack a patients organs, such as their kidneys, and quickly get them into serious medical trouble.  This level of life-threatening lupus involves only the smallest percent of lupus patients. The key for all lupus patients is to get prompt medical attention, and to interrupt every single flare as fast as possible.

Lupus Foundation of America leads in lupus awareness

The role of lupus awareness in lowering mortality rates

One of my passions is helping spread two kinds of lupus awareness.  Early diagnosis and treatment leads to less escalation of lupus severity, and that can mean lower mortality rates.

First, lupus patients need to know how to look at their disease in a way that will allow them to be victorious in reaching their goals and dreams.  They need to know how to quickly get the medical care they need, and to find their best niche for happiness and a productive life.  They need to be encouraged to cope with the hard parts of lupus, and to be resilient and to not let lupus destroy them or their joy.

Second, other people need to know more about lupus.  Doctors, employers, family, friends and the community need to understand lupus better.  They need to understand the importance of research, and more public involvement raising funding for research will help this important lupus research continue.

LFA Lobbying

LFA lobbying in Washington, DC for lupus research funding

I heartily support the efforts of the Lupus Foundation of America (LFA) in getting the word out to raise lupus awareness, and to encourage financial investment in major lupus research.   One of those activities is a well-organized annual grass-roots congressional lobbying campaign, involving patients from all over the United States.

Once a year, members of the Lupus Foundation of America converge on Washington, D.C.  and arrange meetings with congressmen and senators to lobby for specific research funding and other critical education and clinical trials and doctor education.  This lobbying that I participated years ago helped get funding for research in biologic drugs at the National Institutes of Health. We sat down in senators’ and representatives’ offices and talked to them about lupus, and asked them to support specific bills and efforts to fund lupus research.   LFA lobbying efforts have been successful, and much-needed research has received essential federal funding over many recent fiscal years.

Fruit of my lobbying efforts

Reaping benefits of my own lupus lobbying efforts!

A few years after my first lobbying experiences, when lupus drugs that NIH had been researching moved into clinical trials, I participated in a phase III clinical trial for  the biologic drug, Rituximab.  The two infusions I received immediately stopped lupus from attacking my liver and central nervous system, kept me working, and helped me reclaim a more normal personal and professional life.  I enjoyed a near remission for over five years and my lupus quieted down.  Now, I am being helped by another biologic drug, Belimumab, that came to market through later research and clinical trials and was ultimately approved by the FDA just for lupus.

Celebrating Lupus Awareness Month, May 2012

I never expected when I went to Washington to lobby for lupus research funding, that I would enjoy fruits of my lobbying efforts in my lifetime!  What could be better than that?

Today, I am celebrating the progress of in lupus research and treatment achieved over the last decade, on this, the last day of Lupus Awareness Month for 2012!  I trust this series of daily May posts about “31 Lupus Facts” has been informative, encouraging and helpful to you in your personal connection to lupus.

Coping with Lupus: Fact #16 – Discoid is the most common lupus

Coping with Lupus: Discoid lupus (the most common form of skin lupus) accounts for approximately 10 percent of all cases of lupus and occurs in 20 percent of those with systemic lupus.  My discoid lupus was most pronounced before I began taking Plaquenil, and after this first baseline drug treatment started, my rashes cleared up on my face, eyelids, hairline, scalp, chest, arms and thighs.  Now, occasionally a few discoid rashes between my fingers, on my forehead or cheek, or my hairline.

Cutaneous lupus

Forms of cutaneous lupus

The Lupus Foundation of America describes forms of cutaneous lupus in an article on photo-sensitivity and lupus:

1) Acute cutaneous lupus erythematosus (ACLE):

  • This is also known as the “butterfly rash” of lupus and occurs over the cheeks and nose.
  • It often comes on after sun exposure, and is associated with lupus flares.
  • ACLE usually heals within weeks without scarring.

2) Discoid lupus erythematosus (DLE):

  • The term “discoid” refers to the disk-shaped lesions of the rash.
  • The rash occurs mainly on sun-exposed sites.
  • The lesions develop slowly and heal over several months, and may cause scarring.

3) Subacute lupus erythematosus (SCLE):

  • SCLE is highly photosensitive.
  • It usually shows up as many red, circular shapes on the chest, back and arms.
  • It is often a little scaly, resembling psoriasis.
  • This form of lupus is particularly associated with antibodies in the blood to the Ro protein (mentioned above).
  • SCLE tends to heal over weeks or months and is usually non-scarring.
  • It frequently comes back after more sun exposure.

Both SCLE and DLE may occur on their own without the presence of systemic lupus.  Although systemic lupus occasionally develops in people who first have DLE or SCLE, it tends to be a milder illness than the usual form of SLE.

Topical steroids

Slather on the steroids!

A Lupus Foundation of America research report about a new drug, Efalizumab, in the Treatment of Discoid Lupus Erythematosus discusses the following about discoid lupus.

Discoid lupus is a form of lupus that affects the skin (cutaneous lupus). In most cases the discoid lupus rash appears on the face, neck, or scalp, though it can also show up on other areas of the skin. Severe discoid lupus may result in scarring. The treatments that are used most often for severe discoid lupus are strong immunosuppressants that may have significant side effects, especially when used over long periods of time.

A search on www.webmd.com for drugs used to treat discoid lupus, returned a list that included oral Plaquenil/hydroxychloroquine (brand name/generic,) Thalomid, and Thalidomide, the injectable drugs Kenalog, triamcinolone acetonide and Aristospan Intralesional, and a very long list of 106 different topical steroid medications for application to the lupus discoid skin lesions.

Drugs for Cutaneous Lupus

Thalidomide is a drug that has a strong negative stigma about its known relationship to birth defects in the babies of women who used it during pregnancy for their morning sickness. It has been found to be effective in treating some cases of lupus.

Understanding Lupus Fact #4 – Immunity off course

Understanding Lupus: In lupus, something goes wrong with the immune system, which is the part of the body that fights off viruses, bacteria, and germs. The result is the production of auto-antibodies that cause inflammation.

I used to try to understand the biology of all the issues going on with my immune system, but the more tried to learn about it, the more I realized the science was a lot more complicated than I wanted to bend my brain around.  The best I could understand was that my body created antibodies that attack connective tissue cells, and the result is Lupus.  However, now I know this idea is not quite correct.

Joan T. Merrill, M.D.

Recently, I heard a presentation that clearly explained some ideas about lupus response that I had never heard before, and it helped me understand the autoimmunity of Lupus a little better.

Dr. Joan T. Merrill, the Medical Director of the Lupus Foundation of America, recently spoke to lupus patients at an educational event in Phoenix, Arizona.  Dr. Merrill is also a research professor in the Department of Medicine at the University of Oklahoma Health Sciences Center, and an adjunct associate professor in the Department of Medicine at the New York University Medical Center.

Dr. Merrill encouraged changing the thinking about lupus as the body attacking itself.  Instead, she proposed this very different concept, as she also discusses at the U of O web site:

“[Think about] Lupus as an imbalance of the immune system rather than the immune system as some kind of enemy to a lupus patient. It’s there to defend us, not to attack us, but somehow, in lupus, it has become overactive in its defense, leading to excessive inflammation and collateral damage to the body.

The medicines used for lupus now work to suppress the immune system. But they also have unacceptable side effects and can impair the ability of the immune system to keep a person healthy, leading to serious infections and other unwanted consequences.

Instead, we’re looking for treatments that restore the balance of the immune system, such as new “biologic” treatments that can drill down and target even the tiny, individual proteins of the immune system, restoring its proper balance.”

A new way to look at lupus!

Dr. Merrill summarized by explaining that the same factors that go awry to cause lupus, also contribute to the survival of the human race.  After hearing her, I now understand that an ever-changing and adapting immune system is essential to fighting constantly mutating viruses and germs, and this aspect of our human body’s design helps ensure the survival of the human race.

So, perhaps we can now look at our lupus as a necessary evil, since the same feature of human immune system’s design that allows lupus to develop in some people, also works in all of us to fight disease and help keep the rest of the world alive.  Because of this aspect of the human immune system, some people developing auto-immunity is inevitable.

This was a very fresh perspective about lupus! We know have a plausible answer to a lupus patient’s question, “Why me?”

You can learn more about Dr. Merrill’s research programs at the University of Oklahoma Health  Sciences Center, Department of Medicine, Clinical Pharmacology Research Program.

Lupus spoof article about a miracle cure

Disclaimer:  Please be advised that the following phantom research report has absolutely no connection with empirical scientific or medical research, neither express nor implied, and is guaranteed to be genuine spoof in each term and condition for which the specified non-treatment is prescribed.

Monarch Institute of Advanced Lupus Studies

Late last week, Dr. Metam Orfisis and Dr. Raptina C. Ocoon of the Monarch Institute for Advanced Lupus Studies announced a breakthrough discovery in the treatment of excessive color variation syndrome affecting the wardrobes of lupus patients.

Measurable mood elevation and reproducible results in monochromatic colorization phenomenon occurred when lupus patients were compliant with instructions to dress in purple garments during Lupus Awareness Month.

Although other measurable improvements in their lupus symptoms could not be verified by the results of the study, the colorization improvements were statistically significant in raising lupus awareness and improving the emotional perspectives of patients involved in the study.

anecdotal reports of patient fondness for butterflies

An unexpected outcome of their joint research was several anecdotal reports of patient fondness for butterfly images in randomized image preference surveys of the study participants. Further observation and clinical trials to verify these findings are anticipated during the month of May, 2012.

The National Data Bank Research for Lupus

Research that makes a difference

This evening I finished an online survey about my lupus.

For several years, I have been participating in a research project conducted by the National Data Bank for Rheumatic Diseases.  The majority of the world’s current lupus research is conducted in research hospitals and large research centers.  However, this NDB  Lupus project  follows Lupus patients who are “in the community” and who receive their treatment from their own local family doctors and rheumatologists.

Twice each year I answer a series of detailed questions.  Occasionally, I have received a phone call from one of the researchers  at the National Data Bank for Rheumatic Diseases.  They were very interested in talking to me, and getting my personal input as they followed up on a new development or change in my health or treatment.

After finishing tonight’s online survey, it ended with a summary of my lupus status from 2007 through 2011.  I was clear when my remission began ending, with an abrupt change in direction in the summer of 2009.  That summer, I began managing the affairs of my elderly father with advanced dementia.  I traveled weekly between August and October going back and forth between my home and the state where he lived.  After his 2 month hospitalization, I sold his house and eventually moved him nearby to a residential dementia care facility in my city.  The graph shows as the low point in my lupus activity unmistakably!

NDB Lupus Research - My Results

NDB research is concerned with important issues for people with SLE: which treatments are most effective, symptoms, side effects and long term-outcomes. In addition, they are interested in medical costs, quality of life, ability to work and function, price of medications and the extent to which medical treatments actually improve people.

NDB research adds a human touch to the important basic science and immunology work performed at university centers.

NDB performs its research primarily by getting information from people who have SLE.  They do it by mailed questionnaires or secure online web forms.

If you have lupus, they need your help.

Click here to go to their web page to learn more or sign up to help…

Follow

Get every new post delivered to your Inbox.

Join 138 other followers

%d bloggers like this: